Literature DB >> 18443658

Cancer proteomics by quantitative shotgun proteomics.

Emily I Chen1, John R Yates.   

Abstract

A major scientific challenge at the present time for cancer research is the determination of the underlying biological basis for cancer development. It is further complicated by the heterogeneity of cancer's origin. Understanding the molecular basis of cancer requires studying the dynamic and spatial interactions among proteins in cells, signaling events among cancer cells, and interactions between the cancer cells and the tumor microenvironment. Recently, it has been proposed that large-scale protein expression analysis of cancer cell proteomes promises to be valuable for investigating mechanisms of cancer transformation. Advances in mass spectrometry technologies and bioinformatics tools provide a tremendous opportunity to qualitatively and quantitatively interrogate dynamic protein-protein interactions and differential regulation of cellular signaling pathways associated with tumor development. In this review, progress in shotgun proteomics technologies for examining the molecular basis of cancer development will be presented and discussed.

Entities:  

Keywords:  cancer cells; mass spectrometry; protein profiling; quantitative proteomics; shotgun proteomics

Mesh:

Substances:

Year:  2007        PMID: 18443658      PMCID: PMC2352161          DOI: 10.1016/j.molonc.2007.05.001

Source DB:  PubMed          Journal:  Mol Oncol        ISSN: 1574-7891            Impact factor:   6.603


  167 in total

Review 1.  Stable isotope-coded proteomic mass spectrometry.

Authors:  Michael B Goshe; Richard D Smith
Journal:  Curr Opin Biotechnol       Date:  2003-02       Impact factor: 9.740

2.  Biomarker discovery in urine by proteomics.

Authors:  James X Pang; Nicole Ginanni; Ashok R Dongre; Stanley A Hefta; Gregory J Opitek
Journal:  J Proteome Res       Date:  2002 Mar-Apr       Impact factor: 4.466

3.  Phosphoproteome analysis of HeLa cells using stable isotope labeling with amino acids in cell culture (SILAC).

Authors:  Ramars Amanchy; Dario E Kalume; Akiko Iwahori; Jun Zhong; Akhilesh Pandey
Journal:  J Proteome Res       Date:  2005 Sep-Oct       Impact factor: 4.466

Review 4.  Contemporary mass spectrometry for the direct detection of enzyme intermediates.

Authors:  Neil L Kelleher; Leslie M Hicks
Journal:  Curr Opin Chem Biol       Date:  2005-10       Impact factor: 8.822

5.  A comparative evaluation of software for the analysis of liquid chromatography-tandem mass spectrometry data from isotope coded affinity tag experiments.

Authors:  Robert Moulder; Jan-Jonas Filén; Jussi Salmi; Mikko Katajamaa; Olli S Nevalainen; Matej Oresic; Tero Aittokallio; Riitta Lahesmaa; Tuula A Nyman
Journal:  Proteomics       Date:  2005-07       Impact factor: 3.984

6.  Quantitative analysis of modified proteins and their positional isomers by tandem mass spectrometry: human histone H4.

Authors:  James J Pesavento; Craig A Mizzen; Neil L Kelleher
Journal:  Anal Chem       Date:  2006-07-01       Impact factor: 6.986

7.  Multi-Q: a fully automated tool for multiplexed protein quantitation.

Authors:  Wen-Ting Lin; Wei-Neng Hung; Yi-Hwa Yian; Kun-Pin Wu; Chia-Li Han; Yet-Ran Chen; Yu-Ju Chen; Ting-Yi Sung; Wen-Lian Hsu
Journal:  J Proteome Res       Date:  2006-09       Impact factor: 4.466

8.  Anion and cation mixed-bed ion exchange for enhanced multidimensional separations of peptides and phosphopeptides.

Authors:  Akira Motoyama; Tao Xu; Cristian I Ruse; James A Wohlschlegel; John R Yates
Journal:  Anal Chem       Date:  2007-04-06       Impact factor: 6.986

9.  Proteins associated with Cisplatin resistance in ovarian cancer cells identified by quantitative proteomic technology and integrated with mRNA expression levels.

Authors:  Jennifer J Stewart; James T White; Xiaowei Yan; Steven Collins; Charles W Drescher; Nicole D Urban; Leroy Hood; Biaoyang Lin
Journal:  Mol Cell Proteomics       Date:  2005-11-30       Impact factor: 5.911

Review 10.  Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancer.

Authors:  Gen Tamura
Journal:  World J Gastroenterol       Date:  2006-01-14       Impact factor: 5.742

View more
  29 in total

1.  QuantFusion: Novel Unified Methodology for Enhanced Coverage and Precision in Quantifying Global Proteomic Changes in Whole Tissues.

Authors:  Harsha P Gunawardena; Jonathon O'Brien; John A Wrobel; Ling Xie; Sherri R Davies; Shunqiang Li; Matthew J Ellis; Bahjat F Qaqish; Xian Chen
Journal:  Mol Cell Proteomics       Date:  2015-11-23       Impact factor: 5.911

2.  Proteomic analysis of energy metabolism and signal transduction in irradiated melanoma cells.

Authors:  Lu-Bin Yan; Kai Shi; Zhi-Tong Bing; Yi-Lan Sun; Yang Shen
Journal:  Int J Ophthalmol       Date:  2013-06-18       Impact factor: 1.779

Review 3.  Plasma membrane proteomics and its application in clinical cancer biomarker discovery.

Authors:  Rikke Leth-Larsen; Rikke R Lund; Henrik J Ditzel
Journal:  Mol Cell Proteomics       Date:  2010-04-08       Impact factor: 5.911

4.  Up-regulated proteins in the fluid bathing the tumour cell microenvironment as potential serological markers for early detection of cancer of the breast.

Authors:  Pavel Gromov; Irina Gromova; Jakob Bunkenborg; Teresa Cabezon; José M A Moreira; Vera Timmermans-Wielenga; Peter Roepstorff; Fritz Rank; Julio E Celis
Journal:  Mol Oncol       Date:  2009-11-23       Impact factor: 6.603

Review 5.  Targeted proteomic strategy for clinical biomarker discovery.

Authors:  Ralph Schiess; Bernd Wollscheid; Ruedi Aebersold
Journal:  Mol Oncol       Date:  2008-12-11       Impact factor: 6.603

6.  A single lysis solution for the analysis of tissue samples by different proteomic technologies.

Authors:  Pavel Gromov; Julio E Celis; Irina Gromova; Fritz Rank; Vera Timmermans-Wielenga; José M A Moreira
Journal:  Mol Oncol       Date:  2008-10-02       Impact factor: 6.603

7.  Systematic nucleo-cytoplasmic trafficking of proteins following exposure of MCF7 breast cancer cells to estradiol.

Authors:  Gabriella Pinto; Abdulrab Ahmed M Alhaiek; Sepan Amadi; Amal T Qattan; Mark Crawford; Marko Radulovic; Jasminka Godovac-Zimmermann
Journal:  J Proteome Res       Date:  2014-01-24       Impact factor: 4.466

8.  Molecular characterization of apocrine carcinoma of the breast: validation of an apocrine protein signature in a well-defined cohort.

Authors:  Julio E Celis; Teresa Cabezón; José M A Moreira; Pavel Gromov; Irina Gromova; Vera Timmermans-Wielenga; Takuji Iwase; Futoshi Akiyama; Naoko Honma; Fritz Rank
Journal:  Mol Oncol       Date:  2009-02-03       Impact factor: 6.603

Review 9.  Cancer proteomics by quantitative shotgun proteomics.

Authors:  Emily I Chen; John R Yates
Journal:  Mol Oncol       Date:  2007-09       Impact factor: 6.603

Review 10.  Mass spectrometry-based label-free quantitative proteomics.

Authors:  Wenhong Zhu; Jeffrey W Smith; Chun-Ming Huang
Journal:  J Biomed Biotechnol       Date:  2009-11-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.